Bristol Myers Squibb (BMY) Gross Profit (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Gross Profit data on file, last reported at $8.1 billion in Q1 2026.

• Gross Profit for Q1 2026 came in at $8.1 billion, down 1.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.2 billion (up 1.76% YoY), and the FY2025 annual result was $34.3 billion, changed 0.22% from the prior year.
• Gross Profit eased to $8.1 billion in Q1 2026 per BMY's latest filing, from $8.4 billion in the prior quarter.
• Over five years, Gross Profit peaked at $9.2 billion in Q1 2022 and troughed at $7.5 billion in Q4 2024.
• A 5-year average of $8.6 billion and a median of $8.8 billion in 2025 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2024 and 2025: Gross Profit fell 13.77% in 2024, then rose 11.62% in 2025.
• A 5-year view of Gross Profit shows it stood at $8.8 billion in 2022, then declined by 0.92% to $8.7 billion in 2023, then slipped by 13.77% to $7.5 billion in 2024, then rose by 11.62% to $8.4 billion in 2025, then dropped by 4.01% to $8.1 billion in 2026.
• Business Quant data shows BMY's Gross Profit at $8.1 billion in Q1 2026, $8.4 billion in Q4 2025, and $8.8 billion in Q3 2025.